{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(3)"],"submitter":["Pederiva C"],"pubmed_abstract":["<h4>Background</h4>Awareness, diagnosis, and treatment of familial hypercholesterolemia (FH) starting from childhood are a cornerstone of cardiovascular disease prevention. The LIPIGEN Paediatric Group, a network of specialised centres for the diagnosis and management of familial genetic dyslipidemia, is an active part of this mission.<h4>Materials and methods</h4>This is the second exploratory survey organised within the LIPIGEN (LIpid transPort disorders Italian GEnetic Network) paediatric centres. A digital questionnaire consisting of 16 questions was proposed to the principal investigators of 35 LIPIGEN centres in September 2023. We analysed the main FH screening strategies implemented in Italy, which are the referral characteristics to the lipid clinics and clinical and biochemical cr"],"journal":["Children (Basel, Switzerland)"],"pagination":["288"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11941534"],"repository":["biostudies-literature"],"pubmed_title":["Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group."],"pmcid":["PMC11941534"],"pubmed_authors":["Bucci M","Calabro P","Sbrana F","Arca M","Passaro A","Pisciotta L","Zenti MG","Galimberti F","Calandra S","Carugo S","Suppressa P","Casula M","Catapano AL","Capra ME","Banderali G","Pellegatta F","Bianconi V","Biolo M","Montalcini T","Cefalu AB","Maroni L","Gatti S","Cocomello N","Iannuzzo G","Pederiva C","Buonuomo PS","Mombelli G","Muntoni S","Sani E","Genovesi S","Guardamagna O","Mandraffino G","Tarugi P","D'Addato S","Scicali R","Minicocci I","Biasucci G","Moriglia S","Beccuti G","Iughetti L","Nascimbeni F","Werba JP","Citroni N","Averna M"],"additional_accession":[]},"is_claimable":false,"name":"Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group.","description":"<h4>Background</h4>Awareness, diagnosis, and treatment of familial hypercholesterolemia (FH) starting from childhood are a cornerstone of cardiovascular disease prevention. The LIPIGEN Paediatric Group, a network of specialised centres for the diagnosis and management of familial genetic dyslipidemia, is an active part of this mission.<h4>Materials and methods</h4>This is the second exploratory survey organised within the LIPIGEN (LIpid transPort disorders Italian GEnetic Network) paediatric centres. A digital questionnaire consisting of 16 questions was proposed to the principal investigators of 35 LIPIGEN centres in September 2023. We analysed the main FH screening strategies implemented in Italy, which are the referral characteristics to the lipid clinics and clinical and biochemical cr","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2025-06-25T03:04:30.216Z","creation":"2025-06-25T03:04:30.216Z"},"accession":"S-EPMC11941534","cross_references":{"pubmed":["40150571"],"doi":["10.3390/children12030288"]}}